6 results
Anti-IL6 Agents (Tocilizumab, Siltuximab) in COVID19

IL-6 activates T cells and macrophages, among other cell types (see
Siltuximab) in COVID19 ... respiratory tract infection ... anti-IL6 mAb) #AntiIL6 ... #Pharmacology # ... Management #Medications
Drugs Used for the Treatment of COVID-19 Infection

** Editor Note (from ophthalmology MD input) - Hydroxychloroquine/chloroquine
-19 Infection ... highlighted circle= clinical ... smfarmhosp_smfh #Drugs #Medications ... #Pharmacology # ... Table #Management
IDSA Recommendations for Preventing and Treating Chagas Disease (American Trypanosomiasis) in HIV-AIDS
Preventing Clinical Disease
Indication:  Individuals
Clinical Disease ... Indication: Individuals ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology
Guillain-Barre Syndrome - Summary

Acute AIDP that presents with rapidly progressive flaccid weakness

Epidemiology:
 • 1-2 cases/100,000 per
response preceding infection ... like illnesses, COVID ... Guillain-Barre Clinical ... Syndrome #diagnosis #management ... #treatment #neurology
IDSA Recommendations for Preventing and Treating Histoplasma Capsulatum Infections in HIV-AIDS
Indications for Initiating Primary Prophylaxis:
 •
Recommendations for Preventing ... on ART (BIII) Indication ... weeks or until clinically ... #Treatment #management ... #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
Recommendations for Preventing ... disease based on clinical ... #Treatment #management ... opportunistic #infections ... #HIVAIDS #pharmacology